Rchr
J-GLOBAL ID:201801016753892437   Update date: Feb. 01, 2024

Po-sung Chu

チョ ハクショウ | Po-sung Chu
Affiliation and department:
Job title: 専任講師
Research field  (2): Immunology ,  Gastroenterology
Research keywords  (5): autoimmune hepatitis ,  Liver failure ,  Viral hepatitis ,  Immunology of liver diseases ,  Liver fibrosis
Research theme for competitive and other funds  (4):
  • 2022 - 2025 Analyses and applications of novel anti-fibrotic treatment for cirrhosis via the gut-liver axis
  • 2019 - 2021 Mechanism of the Plasticity of Innate Immunity during Metabolic Re-compensation in Liver Cirrhosis
  • 2016 - 2019 Role of gut microbiota in the pathogenesis of primly sclerosing cholangitis
  • 2016 - 2019 肝線維化を抑制するRestorative Macrophageの誘導機序の解明
Papers (49):
  • Sota Fujimori, Po-Sung Chu, Toshiaki Teratani, Yosuke Harada, Takahiro Suzuki, Takeru Amiya, Nobuhito Taniki, Ryosuke Kasuga, Yohei Mikami, Yuzo Koda, et al. IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis. JHEP Reports. 2023. 5. 7. 100757-100757
  • Ishigaki Sho, Yasushi Kondo, Yuichiro Ota, Po-Sung Chu, Hironari Hanaoka, Tsutomu Takeuchi, Yuko Kaneko. Successful treatment of refractory enteritis and arthritis with combination of TNF and IL-6 inhibition in patients with ulcerative colitis. Modern Rheumatology Case Reports. 2023
  • Masataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, Eyal Weinstock, Iddo Nadav Weiner, Efrat Khabra, Noa Ben-Ishai, Dana Inbar, Noga Kowalsman, Ron Mordoch, et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nature Communications. 2023. 14. 1. 3261-3261
  • 柏松 褚, 伸宏 中本, 隆典 金井. 急性肝不全の病態解明up to date. 2023
  • Yoichi Takimoto, Po-sung Chu, Nobuhiro Nakamoto, Yuya Hagihara, Yohei Mikami, Kentaro Miyamoto, Rei Morikawa, Toshiaki Teratani, Nobuhito Taniki, Sota Fujimori, et al. Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis. iScience. 2023. 26. 3. 106220-106220
more...
MISC (52):
  • Ryosuke Kasuga, Po-Sung Chu, Nobuhito Taniki, Nobuhiro Nakamoto, Takanori Kanai. SERUM ALBUMIN LEVELS IMPROVE TRANSPLANT-FREE SURVIVAL PREDICTING PERFORMANCE OF CLIF-C ACLF SCORES IN CIRRHOTIC PATIENTS SUFFERED FROM AD/ACLF BEYOND 90 DAYS. HEPATOLOGY. 2022. 76. S914-S915
  • Nobuhito Taniki, Ryosuke Kasuga, Po-Sung Chu, Akihiro Yamaguchi, Hitomi Hoshi, Keisuke Ojiro, Fumihiko Kaneko, Nobuhiro Nakamoto, Takanori Kanai. PRIOR HISTORY OF LOCOREGIONAL THERAPY ASSOCIATES WITH TACE REFRACTORINESS IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2022. 76. S1403-S1403
  • Po-Sung Chu, Fumie Noguchi, Yasushi Hasegawa, Nobuhito Taniki, Rei Morikawa, Nobuhiro Nakamoto, Takanori Kanai. PREDICTION OF IMMUNOSUPPRESSION RESPONSIVENESS, SURVIVAL OUTCOME AND SEVERE INFECTIONS IN CORTICOSTEROIDS-TREATED PATIENTS WITH SEVERE ACUTE-ONSET AUTOIMMUNE HEPATITIS. HEPATOLOGY. 2021. 74. 774A-775A
  • Yuzo Koda, Toshiaki Teratani, Po-Sung Chu, Nobuhito Taniki, Takanori Kanai, Nobuhiro Nakamoto. ROLES OF CD8+TISSUE-RESIDENT MEMORY T CELLS IN LIVER FIBROSIS RESOLUTION. HEPATOLOGY. 2021. 74. 829A-830A
  • 堀江義則, 谷木信仁, Chu Po-sung, 中本伸宏, 金井隆典. Effect of physician-prescribed nalmefene on alcohol intake reduction in patients with alcohol-related liver disease. 肝臓. 2021. 62. 10
more...
Lectures and oral presentations  (17):
  • 「90日以内の再急性非代償化」が非代償性肝硬変患者の予後不良を予測する: 日本ACLF診断基準(案)の 検証および治療戦略の構築に向けて
    (日本肝臓学会 総会 2019)
  • A shorter period of a subsequent episode of acute decompensation of cirrhosis predicts worse outcome: A single-center experience
    (EASL ILC 2019 2019)
  • アルコール性・非アルコール性脂肪性肝硬変における慢性肝不全急性増悪の臨床病態の異同
    (日本消化器病学会 総会 (2018 Tokyo) 2018)
  • Modification of the MELD score with serological fibrosis markers that reflect extracellular matrix remodeling improves prediction of outcome in non-acetaminophen-associated acute liver failure
    (AASLD2017 (Washinton DC) 2017)
  • 当院における肝移植後C型肝炎再発に対するIFN-free DAA治療経験:治療後早期肝合成能の改善からみた治療導入のタイミング
    (JDDW2017 2017)
more...
Education (3):
  • 2009 - 2013 Graduate School of Keio University
  • 1997 - 2004 National Taiwan University School of Medicine Department of Medicine
  • 1994 - 1997 Taipei Municiple Jianguo Senior High School
Professional career (2):
  • 博士(医学) (慶應義塾大学)
  • MD (National Taiwan University)
Work history (3):
  • 2020/08 - 現在 慶應義塾大学 医学部 内科学(消化器) 専任講師
  • 2019/06 - 現在 Department of Internal Medicine (Gastroenterology and Hepatology), School of Medicine, Keio University
  • 2014/06 - 現在 Keio University Department of Gastroenterology and Hepatology, Internal Medicine, School of Medicine Assistant Professor
Awards (6):
  • 2022/01 - 慶應義塾大学医学部内科学教室 症例報告最優秀賞(指導医)
  • 2020/05 - 慶應義塾大学医学部内科学教室 症例報告最優秀賞(指導医)
  • 2018/11 - JDDW2018 若手奨励賞
  • 2018/04 - 日本内科学会 優秀教官賞
  • 2014/10 - 日本肝臓学会 Bristol-Myres Award
Show all
Association Membership(s) (4):
JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  THE JAPAN SOCIETY OF HEPATOLOGY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page